According to data from the Ministry of Health of India, the number of deaths from tuberculosis (TB) in the country decreased by 38% between 2015 and 2025. The mortality rate dropped from 28 to 18 cases per hundred thousand population.
The WHO Global Tuberculosis Report for 2026 indicates that India achieved its first milestone of a 35% reduction in mortality under its TB Control Strategy in 2025, which occurred five years after the initially set deadline of 2020.
The Ministry also reported a successful treatment rate of 94% among patients with drug-sensitive TB. This progress is attributed to enhanced case finding, the use of rapid molecular diagnostics, portable X-ray machines supported by artificial intelligence, timely treatment, and nutritional support.
Nevertheless, drug-resistant TB remains a serious problem: in 2025, only 42% of approximately 3.7 lakh global cases of rifampicin-resistant TB were included in the treatment program. India, along with four other high-burden countries, accounts for about 60% of the global treatment gap.
As part of an intensified campaign, the government identified nearly 15 lakh people with TB who showed no obvious symptoms. Between December 7, 2024, and November 8, 2026, the TB Mukt Bharat Abhiyan initiative covered over 250 million people, during which more than 1.1 billion X-rays and 300 million molecular tests were conducted.
According to the ministry, the campaign detected 4.864 million TB cases, including 1.497 million asymptomatic cases. The first intensive 100-day campaign started in December 2024 in 347 high-priority districts across 33 states and union territories, and was subsequently expanded nationwide. The second 100-day campaign began on March 24 of this year and targets 1.58 million villages and high-risk districts, as well as crowded areas and vulnerable populations.
Identifying asymptomatic cases is crucial because individuals without signs of the disease may not seek medical examination. Active screening helps detect them and direct them to treatment sooner.
The Ministry links the improvement in mortality rates and treatment outcomes to the intensification of case finding, the use of rapid molecular diagnostics, AI-supported portable X-ray machines, timely treatment, and nutritional support.
The Nikshay digital platform supports patient tracking and treatment monitoring, while the Nikshay Poshan program provides nutritional assistance to eligible patients. The Nikshay Mitra initiative mobilizes private individuals and organizations to support people undergoing treatment.
The Ministry stated that in 2025, 67,933 panchayats were declared TB-free, and 96% of the TB program's funding needs were covered by domestic resources.
However, the WHO report notes a significant data gap: estimates of TB incidence in India for the period 2010–2025 are being revised following the completion of the first round of district-level surveillance and national TB prevalence surveys. WHO is expected to update India's profile after technical discussions on the new data, likely in early 2027.
India accounts for approximately one-quarter of the global TB burden. In 2025, 10.6 million people worldwide contracted TB, and 1.13 million people died from the disease. The global decline in TB incidence between 2015 and 2025 was only 14%, significantly less than the target of 50% set by the TB Control Strategy for 2025.